NASDAQ · Shell Companies · USD

Range Capital Acquisition Corp II (RNGT) Stock Analysis

Range Capital Acquisition Corp II (RNGT) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 20, 2026

RNGT

$10.17

$0.00 (0.00%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RNGT with… →

RNGT Key Statistics

As of Oct 20, 2026

Trading

Open: $10.17
Previous Close: $10.17
52-Week Range: 9.90–10.20

Valuation

Market Cap: $318.59M

Financials (FY)

Shares Outstanding: 23.66M

Dividend and dates

Avg Volume: 42.89K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Range Capital Acquisition Corp II (RNGT) has a market capitalization of $318.59M.

RNGT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+1.90%
2025 (partial year)	−0.20%

As of October 20, 2026.

Analysis

Data-derived

Company Overview

Range Capital Acquisition Corp II (RNGT) is capitalised at $318.59M on the latest close. The company sits in the Financial Services sector, in the Shell Companies industry.

Over the past 52 weeks the price has ranged from $9.90 to $10.20. The most recent close on file for RNGT is $10.17, dated October 20, 2026. The close was unchanged from the previous session. The latest close sits 2.75% above that 52-week low.

Valuation Assessment

The stored price history starts on November 24, 2025, and the total return since then is +1.70%.

Growth & Income

The record shows no dividend for RNGT.

So far in 2026 the total return is +1.90%.

Peer Comparison

Range Capital Acquisition Corp II (RNGT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Range Capital Acquisition Corp II	RNGT	$318.59M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Range Capital Acquisition Corp II has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Range Capital Acquisition Corp II

Range Capital Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Cold Spring Harbor, New York.

Visit website →